The effect of V(III)-adenine complex on yeast as a model of eukaryotic cells

Journal of Biochemistry

Volumn 141, Issue 4, 2007, Pages 545-552

  Pia̧tkowski, Jerzy ^a   Podsiadły, Halina ^a   Bukietyńska, Krystyna ^a  

^a UNIVERSITY OF WROC AW   (Poland)

Author keywords

Adenine; Anti cancer drugs; Cancer treatment; Vanadium complex compound; Yeast

Indexed keywords

ADENINE; CYTOTOXIC AGENT; VANADIUM DERIVATIVE; ANTINEOPLASTIC AGENT; VANADIC ACID;

ABSORPTION SPECTROPHOTOMETRY; AQUEOUS SOLUTION; ARTICLE; CELL GROWTH; CELL PH; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; EUKARYOTIC CELL; MUTAGENESIS; NONHUMAN; YEAST; YEAST CELL; CYTOLOGY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; PH; SACCHAROMYCES CEREVISIAE;

EUKARYOTA;

ADENINE; ANTINEOPLASTIC AGENTS; EUKARYOTIC CELLS; HYDROGEN-ION CONCENTRATION; SACCHAROMYCES CEREVISIAE; VANADATES;

EID: 38449091326     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvm062     Document Type: Article

References (33)

1. Thompson, K.H., McNeill, J.H., and Orvig, C. (1999) Vanadium compounds as insulin mimics. Chem. Rev. 99, 2561-2571
2. Sakurai, H., Tamura, A., Fugono, J., Yasui, H., and Kiss, T. (2003) New antidiabetic vanadyl - pyridone complexes: effect of equivalent transformation of coordinating atom in the ligand. Coord. Chem. Rev. 245, 31-37
3. Shechter, Y., Goldwaser, I., Mironchil, M., Fridkin, M., and Getel, D. (2003) Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes. Coord. Chem. Rev. 237, 3-11
4. Crans, D.C., Smee, J.J., Gaidamauskas, E., and Yang, L. (2004) The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem. Rev. 104, 848-902
5. Xie, M., Gao, L., Li, L., Liu, W., and Yan, S. (2005) A new orally active antidiabetic vanadyl complex - bis(α-furancarboxylato) oxovanadium(IV). J. Inorg. Biochem. 99, 546-551
6. Melchior, M., Rettig, S.J., Liboiron, B.D., Thompson, K.H., Yuen, V.G., McNeill, J.H., and Orvig, C. (2001) Insulin-Enhancing vanadium(III) complexes. Inorg. Chem. 40, 4686-4690
7. Etcheverry, S.B., Crans, D.C., Keramidas, A.D., and Cortizo, A.M. (1997) Insulin - mimetic action of vanadium compounds on osteoblast-like cells in culture. Arch. Biochem. Biophys. 338, 7-14
8. Williams, P.A.M., Barrio, D.A., Etcheverry, S.B., and Baran, E.J. (2004) Characterization of oxovanadium(IV) complexes of D-gluconic and D-saccharic acids and their bioactivity on osteoblast-like cells in culture. J. Inorg. Biochem. 98, 333-342
9. Hall, I.H., Durham, R.W., Tram, M.Jr., Mueller, S., Ramachanadran, B.M., and Sneddon, L.G. (2003) Cytotoxicity and mode of action of vanada- and niobatricarbadecaboranyl monohalide complexes in human HL-60 promyelocytic leukemia cells. J. Inorg. Biochem. 93, 125-131
10. El-Naggar, M.M., El-Waseef, A.M., El-Halafawy, K.M., and El-Sayed, I.H. (1998) Antitumor activities of vanadium(IV), managanese(IV), iron(III), cobalt(II) and copper(II) complexes of 2-methylaminopyridine. Cancer Lett. 133, 71-76
11. Djordjevic, C. (1995) Metal Ions in Biological Systems Vol. 31, Sigel and Sigel, New York
12. Evangelou, A.M. (2002) Vanadium in cancer treatment. Crit. Rev. Oncol./Hematol. 42, 249-265
13. Thompson, K.H., and Orvig, C. (2001) Coordination chemistry of vanadium in metallopharmaceutical candidate compounds. Coord. Chem. Rev. 219-221, 1061-1081
14. Evangelou, A., Karkabounas, S., Kalpouzos, G., Malamas, M., Liasko, R., Stefanou, D., Vlahos, A.T., and Kabanos, T.A. (1997) Comparison of the therapeutic effects of two vanadium complexes administrated at low doses on benzo-α-pyrene induced malignant tumors in rats. Cancer Lett. 119, 221-225
15. Papaioannou, A., Mahos, M., Karkabounas, S., Liasko, R., Evangelou, A.M., Correia, J., Kalfakakou, V., Pessoa, J.C., and Kabanos, T. (2004) Solid state and solution studies of a vanadium(III)-L-cysteine compound and demonstration of its antimetastatic, antioxidant and inhibition of neutral endopeptidase activities. J. Inorg. Biochem. 98, 959-968
16. Osińska-Królicka, I., Podsiadly, H., Bukietyńska, K., Zemanek-Zboch, M., Nowak, D., Suchoszek-Łukaniuk, K., and Malicka-Blaszkiewicz, M. (2004) Vanadium(III) complexes with L-cysteine - stability, speciation and the effect on actin in hepatoma Morris 5123 cells. J. Inorg. Biochem. 98, 2087-2089
17. Bukietyńska, K., and Krot-Łacina, K. (2001) Vanadium(III) interaction with adenine. Polyhedron. 20, 2353-2361
18. Zimmerman, F.K. (1973) A yeast strain for visual screening for the two reciprocal products of mitotic crossing over. Mutat Res. 21, 263-269
19. Botstein, D., Chervitz, S.A., and Cherry, J.M. (1997) Yeast as a model organism. Science 277, 1259-1260
20. Dujon, B., Alexandraki, D., Andre, B., Ansorge, W., Baladron, V., Ballesta, J.P.G., Banrevi, A., Bolle, P.A., Bolotin-Fukuhara, M., and Bossier, P. (1994) The complete sequence of chromosome XI of Saccharomyces cerevisiae. Nature 369, 371-378
21. Feldman, H., Aigle, M., Aljinovic, G., Andre, B., Baclet, M.C., Barthe, C., Baur, A., Becam, A.M., Biteau, N., and Boles, E. (1994) Complete DNA-sequence of Yeast chromosome II. EMBO J. 13, 5795-5809
22. Bassett, D.E.Jr., Boguski, M.S., and Hieter, P. (1996) Yeast genes and human disease. Nature 379, 589-590
23. Tettelin, H., Agostoni Carbone, M.L., Albermann, A., Albers, M., Arroyo, J., Backes, U., Barreiros, T., Bertani, I., Bjourson, A.J., and Bruckner, M. (1997) The nucleotide sequence of Saccharomyces cerevisiae chromosome VII. Nature 387, 81-84
24. Crans, D.C., Yang, L., Alfano, J.A., Chi, L.-H., Jin, W., Mahroof-Tahir, M., Robbins, K., Toloue, M.M., Chan, L.K., Plante, A.J., Grayson, R.Z., and Willsky, G.R (2003) (4-Hydroxypyridine-2,6-dicarboxylato)oxovanadate(V) - a new insulin-like compound: chemistry, effects on myoblast and yeast cell growth and effects on hyperglycemia in rats with STZ-induced diabetes. Coord. Chem. Rev. 237, 13-22
25. Crans, D.C., Smee, J.J., Gaidamauskiene, E.G., Anderson, O.P., Miller, S.M., Jin, W., Gaidamauskas, E., Crubellier, E., Grainda, R., Chi, L.-H., and Willsky, G.R. (2004) Inhibition of yeast growth by molybdenum-hydroxylamido complexes correlates with their presence in media at differing pH values. J. Inorg. Biochem. 98, 1837-1850
26. Zimmerman, F.K. (1970) Induction Mitotic gene conversion by mutagens. Mutat Res. 11, 327-337
27. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J.D. (1989) in Molecular Biology of the Cell. Garland Publishing, Inc., New York and London, second edition
28. Mehta, R.D. and von Borstel, R.C. (1985) Tests for genetic activity in the Yeast Saccharomyces cerevisiae using strains D7-144, XV185-14C, and RM52. in Evaluation of Short-Term Tests for Carcinogens (Ashby, J., de Serres, F.J., Draper, M., Ishidate, M., Margolin, B.H., Matter, B.E., and Shelby, M.D., eds) Vol. 5, pp. 271-284, Progress in mutation research, Elsevier Science Publishers B.V., Amsterdam
29. Willsky, G.R., White, D.A., and McCabe, B.C. (1984) Metabolism of Added Orthovanadate to Vanadyl and High-molecular-weight Vanadates by Saccharomyces cerevisiae. J. Biol. Chem. 259, 13273-13281
30. Friberg, E.G. (2003) pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer. Cancer Lett. 197, 73-80
31. Doughetry, T.J., Gomer, C.J., Henderson, B.W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. (1998) Photodynamic therapy. J. Nat. Cancer I. 90, 889-905
32. Zimmerman, F.K. (1973) A yeast strain for visual screening for the two reciprocal products of mitotic crossing over. Mutat Res. 21, 263-269
33. Zimmerman, F.K., Kern, R., and Rosenberger, H. (1975) A yeast strain for simultaneous detection of induced mitotic crossing over, gene conversion and reverse mutation. Mutat Res. 28, 381-388